Doliver Advisors’s Core Scientific CORZ Stock Holding History

Doliver Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,470	Closed	-$124K	–	160
2024 Q3	$124K	Buy	+10,470	New	+$108K	0.03%	151

Other funds holding CORZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

OWP

ORG Wealth Partners Dallas, Texas $668M AUM 45.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

HPM

Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return

JCM

JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return

Doliver Advisors's CORZ Position: Q4 2024 in Review

Doliver Advisors sold out of Core Scientific (CORZ) in Q4 2024, closing a stake of 10,470 shares — an estimated $124K sold.

Doliver Advisors first reported a position in CORZ in Q3 2024 and held it in 1 quarter. The position peaked at $124K in Q3 2024. 313 funds tracked by Wall St. Rank hold CORZ as of Q4 2024.

Doliver Advisors reported no remaining Core Scientific position as of Q4 2024 after selling out during the quarter.
Doliver Advisors sold 10,470 Core Scientific shares in Q4 2024, an estimated $124K.
Doliver Advisors first reported a position in Core Scientific in Q3 2024 and held it in 1 quarter.
Doliver Advisors's Core Scientific position peaked at $124K in Q3 2024.
313 funds tracked by Wall St. Rank held Core Scientific as of Q4 2024.

Based on Doliver Advisors's 13F filing for Q4 2024, filed 6 Jan 2025.